Prevalence proportion of COVID -19 cases within the medical laboratory services staff and within international HCWs job categories. by Kerry Sidwell Wilson (12890013)

Subjects:

Forecasts of cancer patients’ medical use (sex/ admission cases). by Jinah Sim (15140709)

Forecasts of cancer patients’ medical use (cancer type/cases). by Jinah Sim (15140709)

Forecasts of cancer patients’ medical use (cancer type/cases). by Jinah Sim (15140709)

Forecasts of cancer patients’ medical use (age/admission cases). by Jinah Sim (15140709)

Modeling approach to estimate the total number of incident COVID-19 cases among increased risk patients of Mass General Brigham (June to December 2022) that contributed to the observed hospitalizations and deaths. by Scott Dryden-Peterson (227433)

Subjects:

S1 Data - by Xuwen Gao (375540)

Subjects:

Supplementary Material for: Clinical Implications of Decreased Computed Tomography Value after Ramucirumab in Advanced Gastric Cancer by Izawa N. (6834062)

“…<b><i>Conclusions:</i></b> Patients with aGC treated with ramucirumab experienced a significant decrease of CT value of tumors and had an association between the rate of CT value change and PFS. …”

Onset of COVID-19 from January to July 2020 in Zhejiang Province, China. by Haocheng Wu (559031)

Subjects:

The numerical solution of model (1) for infected compartment vs. time with different scenarios of Phase 1 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases. by Sara K. Al-Harbi (12418482)

“…<p>The numerical solution of model <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0265779#pone.0265779.e002" target="_blank">(1)</a> for infected compartment vs. time with different scenarios of Phase 1 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases.…”

Correlation between confirmed COVID-19 cases in Indigenous peoples and deforestation: before and after vaccination. by Humberto Laudares (21213192)

Subjects:

The numerical solution of model (1) for infected compartment vs. time with different scenarios of Phase 4 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases. by Sara K. Al-Harbi (12418482)

“…<p>The numerical solution of model <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0265779#pone.0265779.e002" target="_blank">(1)</a> for infected compartment vs. time with different scenarios of Phase 4 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases.…”

Supplementary Material for: Scleroderma Secondary to Pembrolizumab: A Case Report and Review of 19 cases of anti PD-1-induced scleroderma. by Farrugia S. (16880841)

“…Immune checkpoint inhibitors are increasingly being used to treat various malignancies. …”

Dynamic coefficients between daily new COVID-19 cases per 1 million population and Type 1, 2, or 3 mobility metrics. by Weiyu Luo (4782711)

Subjects:

P-values of the dynamic coefficients between daily new COVID-19 cases per 1 million population and Type 1 mobility metrics. by Weiyu Luo (4782711)

Subjects:

S1 Data - by Nádia Cristina Pinheiro Rodrigues (9867386)

Subjects:

Clinical characteristics of COVID-19. by Polrat Wilairatana (50854)

Subjects:

Associations between demographic factors and IPC practices and COVID-19 infection. by Ala Bin Tarif (13020471)

Subjects:

Maternal Deaths from COVID-19 in Brazil: Increase during the Second Wave of the Pandemic by Carlos André Scheler (13253751)

An epidemic curve of the incidence of COVID-19 cases within medical laboratory services staff compared to the general South African population. by Kerry Sidwell Wilson (12890013)

Subjects: